Northwest Biotherapeutics | NWBO - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Agenus USD 169.66M 146.06M 2025-12
AstraZeneca USD 25.96B 177M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Eisai JPY 134.78B 12M 2026-03
Infinity Pharmaceuticals USD 0 0 2022-06
Merck USD 46.67B 77M 2026-03
Northwest Biotherapeutics USD 31.8M 11.49M 2025-09
Pfizer USD 60.57B 1.08B 2026-03
Plus Therapeutics USD 3.79M 322K 2022-12
Roche Holding CHF 27.43B 966M 2025-12